Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
14.29B | 13.10B | 12.67B | 12.33B | 11.64B | Gross Profit |
3.13B | 2.80B | 2.67B | 2.49B | 1.89B | EBIT |
778.00M | 702.95M | 712.17M | 640.45M | 25.36M | EBITDA |
1.18B | 1.02B | 995.89M | 1.04B | 351.43M | Net Income Common Stockholders |
461.00M | 433.81M | 421.50M | 331.67M | -106.57M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.18B | 2.00B | 1.70B | 1.73B | 1.75B | Total Assets |
9.47B | 8.86B | 8.51B | 8.49B | 8.69B | Total Debt |
2.34B | 2.36B | 2.48B | 2.84B | 3.55B | Net Debt |
163.00M | 361.55M | 775.71M | 1.11B | 1.79B | Total Liabilities |
5.61B | 5.39B | 5.36B | 5.67B | 6.17B | Stockholders Equity |
3.86B | 3.47B | 3.15B | 2.82B | 2.52B |
Cash Flow | Free Cash Flow | |||
531.00M | 577.75M | 425.20M | 707.21M | -25.01M | Operating Cash Flow |
1.01B | 1.04B | 802.21M | 1.04B | 260.35M | Investing Cash Flow |
-338.00M | -538.99M | -419.61M | -190.59M | -380.35M | Financing Cash Flow |
-166.00M | -227.91M | -437.90M | -748.80M | 126.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥24.62B | 13.10 | 4.00% | 0.69% | 1.90% | ||
75 Outperform | ¥4.27B | 8.96 | 1.73% | 1.03% | ― | ||
73 Outperform | ¥3.36B | 11.52 | 2.42% | 2.85% | -5.28% | ||
72 Outperform | ¥4.21B | 9.11 | 2.55% | 9.04% | 6.37% | ||
70 Outperform | ¥18.41B | 18.91 | 3.39% | 9.70% | 45.81% | ||
65 Neutral | $8.91B | 14.97 | 4.70% | 203.30% | 3.50% | -2.45% |